Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.
Ito T, Hashimoto Y, Tanaka Y, Nakaya A, Fujita S, Satake A, Nakanishi T, Konishi A, Hotta M, Yoshimura H, Ishii K, Hashimoto A, Kondo T, Omura H, Shinzato I, Tanaka T, Nomura S.
Ito T, et al. Among authors: nakaya a.
Eur J Haematol. 2019 Aug;103(2):116-123. doi: 10.1111/ejh.13265. Epub 2019 Jun 17.
Eur J Haematol. 2019.
PMID: 31107982
Free PMC article.